Clinical trial
Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
NCT00993031 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 15, 2009
- Completion date
- July 31, 2013
- Enrollment
- 389 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.